We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Saladax Biomedical Inc., announced today that it has received CE mark (Conformité Européenne) approval for its first two products in the new MyCare™ Psychiatry line of rapid tests for antipsychotics